243 related articles for article (PubMed ID: 18591234)
1. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
[TBL] [Abstract][Full Text] [Related]
2. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.
Zhang Y; Romanov G; Bliska JB
Infect Immun; 2011 Nov; 79(11):4322-31. PubMed ID: 21844228
[TBL] [Abstract][Full Text] [Related]
3.
Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
[TBL] [Abstract][Full Text] [Related]
4. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains.
Nörenberg D; Wieser A; Magistro G; Hoffmann C; Meyer C; Messerer M; Schubert S
Int J Med Microbiol; 2013 Dec; 303(8):583-94. PubMed ID: 24018301
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
7. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death.
Monack DM; Mecsas J; Ghori N; Falkow S
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10385-90. PubMed ID: 9294220
[TBL] [Abstract][Full Text] [Related]
8. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
[TBL] [Abstract][Full Text] [Related]
9. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
Sundberg L; Forsberg A
Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
[TBL] [Abstract][Full Text] [Related]
10. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
Logsdon LK; Mecsas J
Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
[TBL] [Abstract][Full Text] [Related]
11. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
Zheng Y; Lilo S; Brodsky IE; Zhang Y; Medzhitov R; Marcu KB; Bliska JB
PLoS Pathog; 2011 Apr; 7(4):e1002026. PubMed ID: 21533069
[TBL] [Abstract][Full Text] [Related]
12. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
13. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
14. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
[TBL] [Abstract][Full Text] [Related]
15. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ.
Lilo S; Zheng Y; Bliska JB
Infect Immun; 2008 Sep; 76(9):3911-23. PubMed ID: 18559430
[TBL] [Abstract][Full Text] [Related]
16. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V; Golenbock DT; Isberg RR
PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
[TBL] [Abstract][Full Text] [Related]
17. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes.
Bliska JB; Brodsky IE; Mecsas J
EcoSal Plus; 2021 Dec; 9(2):eESP00142021. PubMed ID: 34910573
[TBL] [Abstract][Full Text] [Related]
18. Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells.
Fällman M; Andersson K; Håkansson S; Magnusson KE; Stendahl O; Wolf-Watz H
Infect Immun; 1995 Aug; 63(8):3117-24. PubMed ID: 7622239
[TBL] [Abstract][Full Text] [Related]
19. Yersinia pseudotuberculosis-induced calcium signaling in neutrophils is blocked by the virulence effector YopH.
Andersson K; Magnusson KE; Majeed M; Stendahl O; Fällman M
Infect Immun; 1999 May; 67(5):2567-74. PubMed ID: 10225922
[TBL] [Abstract][Full Text] [Related]
20. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
Viboud GI; Bliska JB
Annu Rev Microbiol; 2005; 59():69-89. PubMed ID: 15847602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
